You haven't searched anything yet.
The Nucala Medical team, as part of the Respiratory team within US Medical Affairs at GSK, is dedicated to developing and executing the medical strategy to support Mepolizumab (Nucala™) for patients with severe eosinophilic asthma (SEA), chronic rhinosinusitis with nasal polyps (CRSwNP), eosinophilic granulomatosis with polyangiitis (EGPA) and hypereosinophilic syndrome (HES), to be ambitious for patients so that they can do more, feel better, live longer.
This position will allow the selected candidate to:
Interested in learning more? Register now on our digital learning platform (GSK Get Ahead - Connectr) where you can access interview and assessment hints and tips, speak to a mentor and learn more about life at GSK.
Intern
$102k-143k (estimate)
02/08/2024
04/03/2024